<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoproteins are a group of <z:chebi fb="40" ids="33697">RNA</z:chebi>-binding proteins with a range of key cellular functions, which are dysregulated in <z:mp ids='MP_0002006'>tumorigenesis</z:mp> including regulation of translational and <z:chebi fb="40" ids="33697">RNA</z:chebi> processing </plain></SENT>
<SENT sid="1" pm="."><plain>The aims of this study were to define the <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein expression profile in primary and <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> and to establish the clinicopathologic significance of this expression </plain></SENT>
<SENT sid="2" pm="."><plain>A tissue microarray containing 515 primary <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e>, 224 lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, and 50 <z:mpath ids='MPATH_458'>normal</z:mpath> colon samples was immunostained for 6 <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoproteins </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001425'>Heterogeneous</z:hpo> nuclear ribonucleoprotein I, <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein K, and <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein L displayed the most frequent strong immunoreactivity in primary <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> samples </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0001425'>Heterogeneous</z:hpo> nuclear ribonucleoprotein A1 (P &lt; .001) and <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein U (P = .003) showed significant alterations in nuclear expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> compared with <z:mpath ids='MPATH_458'>normal</z:mpath> colonic epithelium, whereas <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein A1 (P = .001), <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein I (P &lt; .001), and <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein K (P &lt; .001) <z:hpo ids='HP_0000001'>all</z:hpo> showed significant aberrant cytoplasmic immunoreactivity in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>There were also significant differences in cytoplasmic immunoreactivity between the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> and the corresponding lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> for <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein A1 (P = .001), <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein I (P &lt; .001), and <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein K (P = .001) </plain></SENT>
<SENT sid="6" pm="."><plain>Nuclear <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein H (χ(2) = 72.1; P &lt; .001), cytoplasmic <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein I (χ(2) = 28.1; P &lt; .001), and cytoplasmic <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein K (χ(2) = 13.2; P = .04) <z:hpo ids='HP_0000001'>all</z:hpo> showed significant associations with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage </plain></SENT>
<SENT sid="7" pm="."><plain>There was a significant relationship between strong nuclear <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoprotein H expression and survival (χ(2) = 14.97; P &lt; .001) </plain></SENT>
<SENT sid="8" pm="."><plain>This study has defined the expression profile of <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoproteins in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and shown that there are significant alterations in both expression and subcellular localization of individual <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> nuclear ribonucleoproteins in this type of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
</text></document>